NIH-funded research R21 grant

Accelerating microbiota recovery to protect against C. difficile

Official title: Accelerating microbiota recovery to protect against Clostridioides difficile

Funded at University of California at Davis · NIH-11398249 · Data updated 2026-11-12

A short-term NIH grant to test ways to speed up gut microbiome recovery after antibiotics to prevent dangerous C. difficile infections in adults.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California at Davis
NIH-funded
Lab location1 site (Davis, United States)
Project startAugust 21, 2025
Project endJuly 31, 2027
Funding year2026
Award (this year)$201,250
NIH project number5R21AI193739-02
Project IDNIH-11398249 on NIH RePORTER

Who could benefit from this research

Could help

Adults 21 and older who are receiving or recently finished antibiotic therapy and are at risk for C. difficile infection.

Less likely to help

People not at risk for C. difficile or those unable to take the studied probiotic or pharmacologic intervention may not benefit.

What this research studies

This project focuses on adults who have recently taken antibiotics and are at risk for C. difficile infection. It will test whether a second-generation probiotic (Anaerostipes caccae) can help the gut microbiome recover faster and restore resistance to C. difficile. It will also explore if activating a specific gut cell pathway (PPAR gamma) pharmacologically can speed recovery of the microbiome and protect against infection. The goal is to identify practical strategies to reduce hospitalizations and severe diarrhea from C. difficile by strengthening the natural defenses of the gut.

Why it matters

Potential benefit: If successful, this work could lead to new ways to prevent C. difficile infections after antibiotic use by promoting faster microbiome recovery.

How similar studies have gone: Prior work shows that restoring a healthy microbiome can reduce C. difficile risk, but this specific probiotic approach and PPAR gamma activation are exploratory.

Where this research is happening

  • University of California at Davis
    Davis, United States
    Active

Researchers

  • Principal investigator: Lee, Jee-Yon — University of California at Davis
  • Study coordinator: Lee, Jee-Yon

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.